The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents

被引:0
作者
Sibanda, T. [1 ]
Okoh, A. I. [1 ]
机构
[1] Univ Ft Hare, Dept Biochem & Microbiol, AEMREG, ZA-5700 Alice, South Africa
基金
新加坡国家研究基金会;
关键词
Antibiotic resistance; resistance modifying agents; plant extracts;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The problem of antibiotic resistance, which has limited the use of cheap and old antibiotics, has necessitated the need for a continued search for new antimicrobial compounds. Understanding the mechanisms of resistance is important in the development of strategies to solving the problem. Active efflux of drugs, alteration of target sites and enzymatic degradations are the strategies by which pathogenic bacteria acquire or develop intrinsic resistance to antibiotics. Multi-drug resistance (MDR) pumps, capable of recognizing and expelling a variety of structurally unrelated compounds from the bacterial cell and conferring resistance to a wide range of antibiotics have since been characterized in many gram positive and gram negative pathogens like Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and, more recently, in mycobacteria. The ability of some chemical compounds (called MDR inhibitors or resistance modifying agents) to modify the resistance phenotype in bacteria by working synergistically with antibiotics in vitro has since been observed. The search for such compounds which can be combined with antibiotics in the treatment of drug resistant infections may be an alternative to overcoming the problem of resistance in bacteria. Crude extracts of medicinal plants stand out as veritable sources of potential resistance modifying agents and the African biosphere promises to be a potential source of such compounds owing to its rich plant species diversity.
引用
收藏
页码:2886 / 2896
页数:11
相关论文
共 101 条
[1]  
AHMAD I, 2006, MICROBIO RES, P1
[2]   Preliminary crystallographic analysis of the antibiotic discharge outer membrane lipoprotein OprM of Pseudomonas aeruginosa with an exceptionally long unit cell and complex lattice structure [J].
Akama, H ;
Kanemaki, M ;
Tsukihara, T ;
Nakagawa, A ;
Nakae, T .
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2005, 61 :131-133
[3]   Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa [J].
Akama, H ;
Matsuura, T ;
Kashiwagi, S ;
Yoneyama, H ;
Narita, SI ;
Tsukihara, T ;
Nakagawa, A ;
Nakae, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (25) :25939-25942
[4]   In vitro antimicrobial and resistance-modifying activities of aqueous crude khat extracts against oral microorganisms [J].
Al-hebshi, N ;
Al-haroni, M ;
Skaug, N .
ARCHIVES OF ORAL BIOLOGY, 2006, 51 (03) :183-188
[5]   AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104 [J].
Baucheron, S ;
Tyler, S ;
Boyd, D ;
Mulvey, MR ;
Chaslus-Dancla, E ;
Cloeckaert, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3729-3735
[6]   BACTERICIDAL SYNERGY BETWEEN PENICILLIN OR AMPICILLIN AND AMINOGLYCOSIDES AGAINST ANTIBIOTIC-TOLERANT LACTOBACILLI [J].
BAYER, AS ;
CHOW, AW ;
MORRISON, JO ;
GUZE, LB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (03) :359-363
[7]  
BETONI JEC, 2006, MEM I O CRUZ, V101
[8]  
Braga LC, 2005, CAN J MICROBIOL, V51, P541, DOI [10.1139/w05-022, 10.1139/W05-022]
[9]  
Brown MH, 2001, J MOL MICROB BIOTECH, V3, P163
[10]   Antibacterial drug discovery in the 21st century [J].
Bush, K .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 :10-17